Placebo-controlled study of oral terbutaline and pseudoephedrine in management of prostaglandin E1-induced prolonged erections

Franklin C. Lowe, Jonathan P. Jarow

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

Prolonged erections, priapism, secondary to pharmacologic stimulation are usually treated by drainage of the corporeal bodies and irrigation with a sympathomimetic. To study the efficacy of oral medical therapy in the treatment of priapism, 75 patients with pharmacologically induced (prostaglandin E 1) prolonged erections were randomized to receive terbutaline, pseudoephedrine, or placebo. Detumescence occurred in 36 percent, 28 percent, and 12 percent, respectively. Terbutaline was significantly better than placebo (p <0.05) in achieving detumescence. The results of this study suggest that oral terbutaline should be considered in the initial management of pharmacologically induced prolonged erections.

Original languageEnglish (US)
Pages (from-to)51-53
Number of pages3
JournalUrology
Volume42
Issue number1
DOIs
StatePublished - 1993
Externally publishedYes

Fingerprint

Pseudoephedrine
Terbutaline
Alprostadil
Priapism
Placebos
Sympathomimetics
Prostaglandins E
Drainage
Therapeutics

ASJC Scopus subject areas

  • Urology

Cite this

Placebo-controlled study of oral terbutaline and pseudoephedrine in management of prostaglandin E1-induced prolonged erections. / Lowe, Franklin C.; Jarow, Jonathan P.

In: Urology, Vol. 42, No. 1, 1993, p. 51-53.

Research output: Contribution to journalArticle

@article{987dc91dd47544838594c028e65c40ee,
title = "Placebo-controlled study of oral terbutaline and pseudoephedrine in management of prostaglandin E1-induced prolonged erections",
abstract = "Prolonged erections, priapism, secondary to pharmacologic stimulation are usually treated by drainage of the corporeal bodies and irrigation with a sympathomimetic. To study the efficacy of oral medical therapy in the treatment of priapism, 75 patients with pharmacologically induced (prostaglandin E 1) prolonged erections were randomized to receive terbutaline, pseudoephedrine, or placebo. Detumescence occurred in 36 percent, 28 percent, and 12 percent, respectively. Terbutaline was significantly better than placebo (p <0.05) in achieving detumescence. The results of this study suggest that oral terbutaline should be considered in the initial management of pharmacologically induced prolonged erections.",
author = "Lowe, {Franklin C.} and Jarow, {Jonathan P.}",
year = "1993",
doi = "10.1016/0090-4295(93)90338-B",
language = "English (US)",
volume = "42",
pages = "51--53",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Placebo-controlled study of oral terbutaline and pseudoephedrine in management of prostaglandin E1-induced prolonged erections

AU - Lowe, Franklin C.

AU - Jarow, Jonathan P.

PY - 1993

Y1 - 1993

N2 - Prolonged erections, priapism, secondary to pharmacologic stimulation are usually treated by drainage of the corporeal bodies and irrigation with a sympathomimetic. To study the efficacy of oral medical therapy in the treatment of priapism, 75 patients with pharmacologically induced (prostaglandin E 1) prolonged erections were randomized to receive terbutaline, pseudoephedrine, or placebo. Detumescence occurred in 36 percent, 28 percent, and 12 percent, respectively. Terbutaline was significantly better than placebo (p <0.05) in achieving detumescence. The results of this study suggest that oral terbutaline should be considered in the initial management of pharmacologically induced prolonged erections.

AB - Prolonged erections, priapism, secondary to pharmacologic stimulation are usually treated by drainage of the corporeal bodies and irrigation with a sympathomimetic. To study the efficacy of oral medical therapy in the treatment of priapism, 75 patients with pharmacologically induced (prostaglandin E 1) prolonged erections were randomized to receive terbutaline, pseudoephedrine, or placebo. Detumescence occurred in 36 percent, 28 percent, and 12 percent, respectively. Terbutaline was significantly better than placebo (p <0.05) in achieving detumescence. The results of this study suggest that oral terbutaline should be considered in the initial management of pharmacologically induced prolonged erections.

UR - http://www.scopus.com/inward/record.url?scp=0027165330&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027165330&partnerID=8YFLogxK

U2 - 10.1016/0090-4295(93)90338-B

DO - 10.1016/0090-4295(93)90338-B

M3 - Article

C2 - 8392235

AN - SCOPUS:0027165330

VL - 42

SP - 51

EP - 53

JO - Urology

JF - Urology

SN - 0090-4295

IS - 1

ER -